Head-to-head comparison
| Property | Semax | Noopept |
|---|---|---|
| Category | Cognitive | Cognitive |
| Legal Status | Research Only | Research Only |
| Primary Route | nasal | oral |
| Half-life | ~2-3 minutes (rapid enzymatic degradation, but downstream effects persist) | ~15–30 minutes (prodrug); active CPG metabolite longer |
| Mol. Weight | 813.93 Da | 318.4 Da |
| Side Effects | Nasal irritation, Headache (rare), Dizziness (rare) | Headache (common, especially without choline supplementation), Irritability at high doses, Brain fog or fatigue |
Key differences
- Chemical class: Semax is a heptapeptide analog of ACTH(4-10); noopept is a synthetic dipeptide derivative (not a true peptide in the traditional sense) with ampakine-like activity.
- Administration: Semax is administered as a nasal spray or subcutaneous injection; noopept is orally bioavailable and taken as a sublingual or oral tablet.
- Mechanism: Semax primarily modulates the melanocortin system and upregulates BDNF; noopept modulates AMPA and NMDA receptors and upregulates both BDNF and NGF (nerve growth factor).
- Regulatory status: Semax is an approved prescription medication in Russia; noopept is classified as a nootropic supplement in Russia.
- Onset and duration: Noopept has rapid onset (15–20 minutes orally) with effects lasting 3–5 hours; semax nasal spray effects last 4–6 hours.
- Potency: Noopept is active at very low doses (10–30 mg orally); semax is typically dosed at 200–600 mcg nasally.
- Neurotrophic profile: Noopept upregulates both BDNF and NGF; semax primarily upregulates BDNF. The dual neurotrophic effect is noopept's distinguishing feature.
The verdict
Both semax and noopept are well-regarded nootropics with neurotrophic properties. Semax has the advantage of prescription drug status in Russia and a stronger clinical evidence base. Noopept has the advantage of oral bioavailability and dual BDNF/NGF upregulation. For convenience and accessibility, noopept is more practical. For clinical evidence quality and established medical use, semax is stronger. Many nootropic enthusiasts cycle or combine both.
Frequently asked questions
Some nootropic protocols combine semax and noopept for broader neurotrophic coverage — semax for BDNF via the melanocortin system and noopept for BDNF and NGF via AMPA/NMDA modulation. No clinical studies have evaluated this combination, but the mechanisms are complementary rather than redundant.
Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) is a synthetic compound derived from a dipeptide structure. It is not a true peptide in the traditional amino acid chain sense but is peptide-derived. Its small size gives it oral bioavailability that most peptides lack.
Both support memory through neurotrophic factor upregulation. Noopept has additional AMPA receptor modulation (an ampakine-like effect) that may specifically enhance memory consolidation. Semax's BDNF effects support long-term neuroplasticity. Individual response varies significantly.
Yes, noopept is orally bioavailable and taken as a sublingual tablet or capsule. Semax requires nasal spray or injection. For convenience, noopept is more practical. For direct CNS delivery, semax nasal spray bypasses the blood-brain barrier more efficiently.
Neither is FDA-approved in the US. Semax is an approved prescription drug in Russia. Noopept is classified as a nootropic supplement in Russia. In the US, both are available as research compounds. Regulatory status should be verified as enforcement varies.